MedPath

Risk reduction in sperm processing for during infertility treatment

Not Applicable
Conditions
Health Condition 1: N469- Male infertility, unspecified
Registration Number
CTRI/2019/12/022447
Lead Sponsor
Department of Clinical Embryology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Male: Patients who can produce ejaculates

For male partner: Patients who can produce ejaculates.

For female partner: Patients who will have good ovarian response for stimulation and >= 12 mature eggs on the day of oocyte pick up.

Exclusion Criteria

Male: Azoospermic patients

Couples:

For male partner:Azoospermic patients

For female partner: Patients who are not having good ovarian response for stimulation and < 12 mature eggs on the day of oocyte pick up.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
From this study, we are expected to understand the basic biochemical and cellular responses of spermatozoa to different sperm processing methods as well as the possibilities to optimize ideal conditions both for normal and abnormal samples to maintain maximum sperm fertilizing ability. Further there will be establishment of the relationship between different sperm processing methods and embryo developmental potential to prevent abnormal ART outcome.Timepoint: 13.08.2019 to 12.08.2022
Secondary Outcome Measures
NameTimeMethod
This study has direct clinical application as the optimized protocols can be incorporated to routine clinical practiceTimepoint: 13.08.2019 to 12.08.2022
© Copyright 2025. All Rights Reserved by MedPath